We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Non-Invasive Technology Monitors Cardiac Output

By HospiMedica staff writers
Posted on 05 Feb 2008
A highly accurate, portable cardiac output monitor provides a noninvasive window to cardiac and hemodynamic function. More...


The Cheetah Reliant monitor provides continuous tracking of cardiac output and other key parameters of cardiac function such as ventricular ejection time, heart rate (HR), and cardiac contractility. The system is based on noninvasive cardiac output monitoring (NICOM) technology, which uses traditional impedance technology that analyzes changes in voltage of electrical currents traversing the patient's chest, in combination with proprietary bioreactance technology, which analyzes frequency related effects. The hybrid analysis helps deal with electrical noise interference, patient movement, respiration, and electrode misplacement.

As a result, NICOM enables a highly precise, accurate, and responsive measurement of cardiac function and hemodynamic status. The system can be used in various clinical settings, including hemodynamic monitoring, heart failure, perioperative care, and hemodialysis, as well as outpatient applications such as cardio-pulmonary-stress testing (CPX) for chronic heart failure (CHF) evaluation and during optimization of bi-ventricular pacemakers. The Cheetah Reliant monitor is a product of Cheetah Medical (Tel Aviv, Israel), and has been approved by the U.S. Food and Drug Administration (FDA).

"Across the world, the healthcare environment struggles to provide quality care to an aging population while dealing with efficiency and economic constraints,” said Yoav Avidor, M.D., CEO of Cheetah Medical. "There is a global push to reduce invasive, costly procedures that can lead to complications and require a highly skilled physician to deploy. Hospitals seek better solutions in terms of efficiency, cost and scalability to more patients who can be treated in less acute settings, without impacting quality of care.”

Cardiac output monitoring has been shown in the context of specific treatment algorithms to reduce morbidity, mortality, and length of hospital stay in a number of conditions including perioperative care, intensive care, and trauma while also providing clinical value in heart failure and dialysis.


Related Links:
Cheetah Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.